0001237899-12-000092.txt : 20121203 0001237899-12-000092.hdr.sgml : 20121203 20121203162139 ACCESSION NUMBER: 0001237899-12-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121129 FILED AS OF DATE: 20121203 DATE AS OF CHANGE: 20121203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aberman Michael S CENTRAL INDEX KEY: 0001487767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 121237736 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-11-29 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001487767 Aberman Michael S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Strategy and Investor Relat Common Stock 2012-11-29 4 M 0 8334.0 24.0 A 18834.0 D Common Stock 2012-11-29 4 F 0 1097.0 182.2 D 17737.0 D Common Stock 2012-11-29 4 F 0 3333.0 182.2 D 14404.0 D Common Stock 2012-11-30 4 S 0 3004.0 180.08 D 11400.0 D Common Stock 2012-11-30 4 S 0 400.0 181.59 D 11000.0 D Common Stock 2012-11-30 4 S 0 200.0 182.39 D 10800.0 D Common Stock 2012-11-30 4 S 0 200.0 183.77 D 10600.0 D Common Stock 2012-11-30 4 S 0 100.0 184.0 D 10500.0 D Common Stock 287.0 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 24.0 2012-11-29 4 M 0 8334.0 D 2020-03-22 Common Stock 8334.0 50002.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 3,004 shares of Company stock on November 30, 2012 at prices ranging from $180.00 to $180.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on November 30, 2012 at prices ranging from $181.29 to $181.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $182.38 to $182.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $183.64 to $183.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests over five years, commencing one year after the date of grant. 12,500 options vest on the first anniversary, 25,000 options vest on the second anniversary, 25,000 options vest on the third anniversary, 25,000 options vest on the fourth anniversary, and 12,500 options vest on the fifth anniversary of the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Michael S. Aberman 2012-11-30